Cargando…
Preparation, Characterization, and In Vivo Pharmacoscintigraphy Evaluation of an Intestinal Release Delivery System of Prussian Blue for Decorporation of Cesium and Thallium
BACKGROUND: Prussian blue (PB, ferric hexacyanoferrate) is approved by US-FDA for internal decorporation of Cesium-137 ((137)Cs) and Thallium-201 ((201)Tl). AIM: Since PB is a costly drug, pH-dependent oral delivery system of PB was developed using calcium alginate matrix system. METHODS: Alginate (...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727830/ https://www.ncbi.nlm.nih.gov/pubmed/29318045 http://dx.doi.org/10.1155/2017/4875784 |